Medicine and Dentistry
COVID-19
95%
Severe Acute Respiratory Syndrome Coronavirus 2
82%
Kidney Graft
35%
Immunopathology
35%
Infection
33%
Disease
29%
Oxidative Stress
25%
Immunoglobulin G Antibody
22%
Humoral Immunity
20%
Immunocompromised Patient
20%
Drive
17%
Observational Study
17%
Fibrosis
17%
Iron Overload
17%
T-Cell Lymphoma
17%
Epstein Barr Virus
17%
Thiol
17%
Organoid
17%
Thalassemia Major
17%
Post-Hoc Analysis
17%
Prospective Cohort Study
17%
Hydrogen Sulfide
17%
Acetylcysteine
17%
Post-COVID-19
17%
Taurine
14%
Antioxidant
12%
COVID-19 Vaccination
8%
Lymphoproliferative Disease
8%
Immune Deficiency
8%
Gasotransmitter
8%
Chronic Kidney Disease
8%
Antivirus Agent
8%
Organ Systems
7%
Kidney Cell
7%
B Cell
7%
T Cell
7%
Seroconversion
5%
Interferon
5%
Pathophysiology
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Disease
76%
Coronavirinae
71%
Infection
53%
Pathophysiology
23%
Thiol
21%
Thalassemia Major
17%
Immunopathology
17%
Fibrosis
17%
Hydrogen Sulfide
17%
Acetylcysteine
17%
Iron Poisoning
17%
Vaccination Policy
17%
Prospective Cohort Study
17%
Syndrome
17%
Virus RNA
17%
Acute Disease
13%
Antioxidant
11%
Thiol Group
10%
Taurine
10%
Gasotransmitter
8%
Biological Marker
8%
Flow Cytometry
8%
Monoclonal Antibody
8%
Comorbidity
8%
Antiviral Drug
8%
Immunomodulating Agent
8%
Antiinflammatory Agent
8%
Repurposing
8%
Physical Disease by Body Function
8%
Anti-Inflammatory Drug
7%
Antivirus Agent
7%
Injury
5%
Keyphrases
COVID-19
73%
Systemic Oxidative Stress
35%
Pathophysiological Mechanisms
35%
Free Thiols
31%
Serum-free
21%
Treatment Options
19%
Management Strategy
19%
Immunopathology
17%
Disease-modifying Therapy
17%
IgG Antibody Titer
17%
Kidney Transplant Recipients
17%
Kidney Organoid
17%
Therapeutic Potential
17%
Viral RNA Shedding
17%
Clinical Phenotype
17%
Post-COVID-19 Condition
17%
Oxidative Stress
12%
Immunodeficiency-associated Lymphoproliferative Disorders
11%
Healthy Controls
9%
SARS-CoV-2 Vaccination
8%
Hospitalized COVID-19
8%
Albumin
7%
Pathophysiology
7%
Chronic Kidney Disease Stage
5%
Serological Response
5%
Seroconversion Rate
5%
Dialysis
5%
Non-hospitalized
5%
